Lenalidomide for the treatment of multiple myeloma in people who have received at least 2 prior therapies

Technology appraisal guidance
Reference number: TA171
Published: 18 June 2009
Last updated: 26 June 2019

Appendix B: proposal paper presented to the Institute's Guidance Executive

Appendix B: proposal paper presented to the Institute's Guidance Executive

Appendix B: proposal paper presented to the Institute's Guidance Executive
05 March 2012
(147.78 Kb 43 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 02 March 2012